Skip to content

Author

Ying Zhang

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access

Isoliquiritigenin ameliorates metabolic dysfunction-associated steatotic liver disease by modulating S100A8-associated MAPK signaling and ferroptosis-related processes

Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) currently lacks effective targeted therapeutic approaches. Although isoliquiritigenin (ISL) exhibits hepatoprotective effects, its precise molecular target remains unclear. This study aims to identify the potential molecular target and mechani...

Ying Zhang, Bing-Qian Li, Ying-Nan Song et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.